ÂÜÀòÂÒÂ×

Meg Krench is an experienced professional in the biotechnology sector, currently serving as an Investor at Sanofi Ventures. Krench holds multiple board observer roles at companies including Eligo Bioscience and QurAlis, and has served as a board guest for an undisclosed neurodegeneration platform company. Krench's academic background includes a Doctor of Philosophy (PhD) in Neuroscience from the Massachusetts Institute of Technology, obtained between 2009 and 2016, and a Bachelor of Science (BS) in Biology from Penn State University, earned from 2005 to 2009.